For more information or confidential assistance
800-306-3180
se habla español

Risperdal Lawsuit Filed in Louisiana District Court

On March 27, 2015, a former Risperdal patient filed a lawsuit in U.S. District Court for the Eastern District of Louisiana against several drug manufacturers, including Janssen Pharmaceuticals and Johnson & Johnson. The complaint is one of several ongoing causes of action against the makers of the powerful antipsychotic drug, which... Read more »

JPML Denies Motion to Centralize Testofen Lawsuits

The Judicial Panel on Multidistrict Litigation (JPML) is a panel of federal judges that is authorized to determine whether civil actions pending in district courts should be moved to one federal court for consolidated pretrial proceedings. This centralization of cases is meant to help conserve judicial resources, reduce chance of duplicative... Read more »

Lawsuit Questions Xarelto Safety

xarelto pill bottle
  Another lawsuit has been transferred to the Xarelto multidistrict litigation (MDL) No. 2592, which is pending in the U.S. District Court for the Eastern District of Louisiana under Judge Fallon. The plaintiff, Cheryl Butler, claims the defendants, Janssen Pharmaceuticals, Bayer Healthcare Pharmaceuticals, et al. fraudulently misrepresented the safety of the... Read more »

Alabama Mother Files Zofran Lawsuit

Premises liability lawyer Los Angeles
An Alabama mother and her nine-year-old son have filed a Zofran lawsuit. The mother’s doctor ordered her to begin taking the drug while she was pregnant, in January 2006, to combat nausea. The baby was born on August 12, 2006 and shortly after, doctors discovered he had a high, narrow... Read more »

Zofran Lawsuit Filed in Montana District Court

In a recent complaint against Zofran manufacturer GlaxoSmithKline (GSK), two Montana parents have alleged significant failures by GSK to properly warn women of the allegedly known risks of congenital birth defects in babies exposed to the drug in utero. The complaint includes the full history of the testing and approval of... Read more »

$2.2 Billion Actos Settlement Offer a Bargain for Takeda?

When is paying $2.2 billion ever a bargain? According to University of Michigan professor and class action settlement expert Eric Gordon, Japanese drug giant Takeda’s decision to offer one of the largest drug settlements in US history to settle 8,ooo pending lawsuits against it may be just that. Actos users... Read more »

Intracranial Hemorrhage Subject of Xarelto Lawsuit

For patients suffering from the condition known as atrial fibrillation – or “A-fib” – an anti-coagulant drug is often used to help prevent the formation of deadly blood clots. For generations, doctors prescribed the drug known as warfarin to A-fib patients, until the newer blood thinning drug Xarelto was introduced... Read more »